日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Investors make a beeline for WuXi AppTec shares

By Cai Xiao | China Daily | Updated: 2018-05-26 11:51
Share
Share - WeChat
Interior view of the headquarters of WuXi Biologics' parent firm, WuXi AppTec, in Shanghai, April 23, 2018. [Photo/IC]

Leading contract research outsourcing provider WuXi AppTec saw its A-share price jump by the daily limit of 10 percent again on Friday after 13 consecutive trading days of gains to 107.36 yuan ($16.80).

The market capitalization of the newly listed company totaled 111.9 billion yuan on Friday, ranked fifth by market capitalization among A-share listed pharmaceutical and biotechnology companies.

Jiangsu Hengrui Medicine Co Ltd, Kangmei Pharmaceutical Co Ltd, Yunnan Baiyao Group Co Ltd and Shanghai Fosun Pharmaceutical Group Co Ltd were the other four firms.

WuXi AppTec became the most profitable new share as investors could earn about 86,000 yuan for every 1,000 shares based on Friday's stock performance.

The trading volume of WuXi AppTec totaled 272 million yuan on Friday, compared with 57.6 million yuan on Thursday.

WuXi AppTec released a statement on Friday afternoon to remind investors of paying attention to the company's operating risks after 14 consecutive trading days of gains.

"The nation levied no tariffs on imported anti-cancer drugs, as well as imported potency drugs, which also forced domestic drug manufacturers to upgrade their products, creating great opportunities for contract research organizations, with WuXi AppTec taking a lead.

"Besides, as the market is opening up, there are limited enterprises that are able to offer qualified products, this explains why the company is favored by investors," said Chen Qiaoshan, senior medical analyst at Beijing-based internet consultancy Analysys.

WuXi AppTech, formerly known as WuXi PharmaTech (Cayman) Inc, was listed at the New York Stock Exchange in 2007 and went private in 2015. WuXi PharmaTech (Cayman) Inc was divided into three companies then: Pharmaceutical Co Ltd listed at China's new third board in 2015, Wuxin Biologics went public in Hong Kong in 2017 and WuXi AppTech, which was listed in May.

Zheng Yiran contributed to this story.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 成人免费影| 一区在线视频 | 美女网站黄在线观看 | 欧美另类视频一区 | 国产精品日韩在线观看 | 久久亚洲第一 | 亚洲精品视频免费观看 | 亚洲国产中文字幕 | 欧美在线观看一区 | 免费毛片在线视频 | 麻豆精品传媒一二三区在线视频 | 国产99久久精品一区二区 | 欧美成人精品一区二区男人看 | 日本九九视频 | 日本欧美一区二区三区视频 | 欧美一区二区免费 | 奇米影视亚洲春色 | 国产精品久久久久久吹潮 | 免费观看一级毛片 | 亚洲国产精品一区二区第一页 | 91精品国产综合久久福利软件 | 欧美 日本 国产 | 国产综合精品久久亚洲 | 狠狠色噜噜狠狠狠狠黑人 | 久久综合九色综合国产 | 免费在线成人 | 视频在线观看一区 | 香港三级午夜理伦三级 | 久久成人一区 | aaaaa国产毛片| 日韩一区二区免费视频 | 成人av在线播放 | 国产免费资源 | 黄色av毛片 | 欧美一区二区三区成人 | 国产欧美日韩一区二区三区四区 | 成人精品网 | 亚洲久久久 | 亚洲视频在线看 | 热久久亚洲 | 亚洲一区二区三区深夜天堂 |